Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE) (COMETE-CARE)
Cancer, Adrenal
About this trial
This is an interventional diagnostic trial for Cancer focused on measuring biological markers, genomics
Eligibility Criteria
Inclusion Criteria Patients 18 years of age and older Patients with an adrenal tumor who will be operated of a potentially malignant adrenocortical carcinoma (ACC) or pheochromocytoma or paraganglioma (MPP) (any stage, any secretion) Patients affiliated with a social security regime Patients who have signed an informed consent Exclusion Criteria Vulnerable populations : minors, pregnant or breastfeeding women, protected adults Patients on AME (state medical aid)
Sites / Locations
- GH Paris Centre, Assistance Publique - Hôpitaux de Paris
Arms of the Study
Arm 1
Arm 2
Other
Other
Patients with ACC
Patients with MPP
These patients will be followed up and proposed a search for targetable molecular alterations
These patients will be followed up and proposed a search for targetable molecular alterations